Belite Bio Inc. - ADRBLTE

13F holders, Q3 2024 (September 30)
15holders +4
6new positions
2sold out
2famous investors
$46.88avg. 13F price*

At the end of Q3 2024, 15 institutions reported holding Belite Bio Inc. - ADR (BLTE) in their 13F filings, up 4 from Q2 2024. 6 opened new positions and 2 sold out. The largest holders were State Street Corp. ($942K), Bank of America Corp. ($631K) and Marshall Wace, LLP ($398K). 2 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Belite Bio Inc. - ADR
CUSIP
07782B104
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 11Q1 2024Q2 2024: 11Q2 2024Q3 2024: 15Q3 2024Q4 2024: 22Q4 2024Q1 2025: 18Q1 2025Q2 2025: 18Q2 2025Q3 2025: 34Q3 2025Q4 2025: 69Q4 2025Q1 2026: 75Q1 2026Q2 2026: 80Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions6$1.1M
Exits2$7.0M

All 13F filers, Q2 2024 → Q3 2024: 48,433 shares bought and 156,302 shares sold, net −107,869 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

State Street Corp. 0.00% Add +28.2% 20,086 $942K
Bank of America Corp. 0.00% Add +13087.3% 13,451 $631K
Marshall Wace, LLP 0.00% New 8,486 $398K
Geode Capital Management, LLC 0.00% No change 6,700 $314K
Citadel Advisors 0.00% New 6,460 $303K
JPMorgan Chase & Co. 0.00% Add +7122.7% 6,356 $298K
XTX Topco Ltd 0.02% New 5,394 $253K
Point72 Asset Management 0.00% Reduce -34.4% 4,800 $225K
Cubist Systematic Strategies, LLC 0.00% New 2,019 $95K
Virtus Advisers, LLC 0.04% Add +2.0% 1,843 $86K
Rhumbline Advisers 0.00% New 1,435 $67K
GAMMA Investing LLC 0.00% Add +103.5% 871 $41K
Morgan Stanley 0.00% Reduce -36.6% 662 $31K
UBS Group AG 0.00% New 128 $6K
Osaic Holdings, Inc. 0.00% No change 8 $375

"% of holder's portfolio" is BLTE's weight in each manager's 13F, not the share of Belite Bio Inc. - ADR the manager owns.